Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Baber

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Nutrition (Burbank, Los Angeles County, Calif.)|August 25, 2004
Hip girth as a predictor of abdominal adiposity in postmenopausal womenChand Raja, Ross Hansen, Rod Baber, et al.
Maturitas|April 21, 2015
Misrepresentation of the risk of ovarian cancer among women using menopausal hormones. Spurious findings in a meta-analysisSamuel Shapiro, John C Stevenson, Alfred O Mueck, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 16, 2017
Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussionDanielle Mazza, Deborah Bateson, Meredith Frearson, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 7, 2017
Reply to 'Response to Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion'Deborah Bateson, Danielle Mazza, Meredith Frearson, et al.
Australian Family Physician|April 8, 2016
Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysisDeborah Bateson, Belinda E Butcher, Catherine Donovan, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Nutrition (Burbank, Los Angeles County, Calif.)|August 25, 2004
Hip girth as a predictor of abdominal adiposity in postmenopausal womenChand Raja, Ross Hansen, Rod Baber, et al.
Maturitas|April 21, 2015
Misrepresentation of the risk of ovarian cancer among women using menopausal hormones. Spurious findings in a meta-analysisSamuel Shapiro, John C Stevenson, Alfred O Mueck, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 16, 2017
Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussionDanielle Mazza, Deborah Bateson, Meredith Frearson, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 7, 2017
Reply to 'Response to Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion'Deborah Bateson, Danielle Mazza, Meredith Frearson, et al.
Australian Family Physician|April 8, 2016
Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysisDeborah Bateson, Belinda E Butcher, Catherine Donovan, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
Pageof 4